Lettruthringout, "Duh!!!" AMRN management must face the fact that the
US market will never be made whole by them. Maybe if they get lucky in
court a BP acquirer can salvage the most value. Europe is where the
most profits could be made if it is ever placed in the right hands.
If JT honestly believes that he can GIA and optimize Vascepa sales then
he needs professional help. He already destroyed one major market,
how could his BOD allow him to destroy the last remaining one as well?
(We as investors should be pushing JT and (is it our BOD or Thero's)
the BOD to get AMRN sold!) And yes Kiwi, I want it to include the
value of Vascepa as an important medication to battle the long-term
effects of COVID-19...but most especially as an effective and safe
CVD product.)
If the analysts following AMRN see this so clearly, then why can't JT and the BOD?
News 
Market Data 
Discover 
AI
